O relatório
Notícias verificadas sobre financiamento, sedes e liderança das empresas mais inovadoras do mundo
32 relatórios e mais
Verastem Oncology Appoints Michael P. Bailey President and CEO
Verastem Oncology appointed director Michael P. Bailey, who spent 16 years at AVEO Pharmaceuticals, as President and CEO effective January 1, 2027, succeeding retiring CEO Daniel Paterson.
Harmony Biosciences Appoints Peter Anastasiou President and Chief Executive Officer
Harmony Biosciences appointed Chief Operating Officer Peter Anastasiou as CEO effective January 1, 2027, succeeding retiring CEO Jeffrey M. Dayno, to lead the company’s next phase of growth.
TETRAPHARM Appoints Rolf Sass Sørensen Chief Executive Officer
TETRAPHARM appointed Rolf Sass Sørensen, formerly of Bavarian Nordic, as CEO to succeed co-founder Martin Rose and lead the Danish biopharmaceutical company’s continued development.
Breye Therapeutics Raises €67.5M Series A for Oral Retinal Disease Drugs
Breye Therapeutics raised an over-subscribed €67.5 million Series A co-led by Mission BioCapital and Novo Holdings to advance danegaptide into a Phase 2 trial.
Altis Labs Raises $25M Series A for AI Clinical-Trial Endpoints
Altis Labs raised a $25 million Series A co-led by OrbiMed and Qiming Venture Partners USA to expand AI endpoints for oncology clinical trials.
Chiesi Appoints David Khougazian Group Chief Executive Officer
Chiesi appointed former Flagship Pioneering executive David Khougazian as Group CEO, succeeding Interim Group CEO Jean-Marc Bellemin, to lead its next phase of innovation-driven growth.
Forus Raises $150M Series C at a $3B Valuation
Forus raised a $150 million Series C at a $3 billion valuation, led by Bain Capital Ventures, with every existing institutional investor reinvesting.
SpyGlass Pharma Opens New Headquarters in Irvine
SpyGlass Pharma opened a 33,000-square-foot headquarters in Irvine, California, on August 27, 2026, moving from its former facility in Aliso Viejo as it prepares for its first product launch.
Amplifica Raises $26M Series B for Injectable Hair Growth Therapies
Amplifica raised an oversubscribed $26 million Series B led by Tasso Partners to advance clinical development of its injectable hair-growth pipeline.
Mostrando 9 relatórios • Página 1 • Categoria: all
Fique à frente do mercado
Receba insights semanais em sua caixa de entrada. Sem spam, apenas inteligência.



